MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
available to common...
-$227M
(-260.99%↓ Y/Y)
Development services &
clinical supply
$556M
Manufacturing & commercial
product supply
$482M
Net earnings(loss)
-$227M
(-260.99%↓ Y/Y)
Income tax expense
-$55M
(-257.14%↓ Y/Y)
Total
$1,038M
Income (loss) from
continuing operations...
-$282M
(-260.23%↓ Y/Y)
Other
(income)expense, net
$4M
(300.00%↑ Y/Y)
Net revenue
$1,037M
(-18.54%↓ Y/Y)
Inter-segment revenue
elimination
-$1M
Operating earnings
-$235M
(-211.37%↓ Y/Y)
Interest expense, net
-$51M
(-54.55%↓ Y/Y)
Gross margin
$180M
(-57.45%↓ Y/Y)
Cost of sales
$857M
(0.82%↑ Y/Y)
Goodwill, impairment loss
$210M
Selling, general, and
administrative expenses
$190M
(-8.21%↓ Y/Y)
Other cost and
expense, operating
$15M
(200.00%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
null (CTLT)
null (CTLT)